Markus Skrifvars

Prof. Markus Skrifvars


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2021 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
JNJerry P. Nolan
Jerry P. Nolan
CSClaudio Sandroni
Claudio Sandroni
Bernd BöttigerBernd Böttiger
Bernd Böttiger
ACAlain Cariou
Alain Cariou
TCTobias Cronberg
Tobias Cronberg
JSJasmeet Soar
Jasmeet Soar

1 December 2003 in Resuscitation
Verified
Journal Article
Closed access
MSMarkus Skrifvars
Markus Skrifvars
VPV. Pettilä
V. Pettilä
PRP.H. Rosenberg
P.H. Rosenberg
MCM. Castrén
M. Castrén

27 August 2020 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
LWLauri Wihersaari
Lauri Wihersaari
NANicholas J. Ashton
Nicholas J. Ashton
MRMatti Reinikainen
Matti Reinikainen
PJPekka Jakkula
Pekka Jakkula
VPVille Pettilä
Ville Pettilä
MSMarkus Skrifvars
Markus Skrifvars
Purpose Neurofilament light (NfL) is a biomarker reflecting neurodegeneration and acute neuronal injury, and an increase is found following hypoxic brain damage. We assessed the ability of plasma NfL to predict outcome in comatose patients after out-of-hospital cardiac arrest (OHCA). We also compared plasma NfL concentrations between patients treated with two different targets of arterial carbon dioxide tension (PaCO2), arterial oxygen tension (PaO2), and mean arterial pressure (MAP). Methods We measured NfL concentrations in plasma obtained at intensive care unit admission and at 24, 48, and 72 h after OHCA. We assessed neurological outcome at 6 months and defined a good outcome as Cerebral Performance Category (CPC) 1–2 and poor outcome as CPC 3–5. Results Six-month outcome was good in 73/112 (65%) patients. Forty-eight hours after OHCA, the median NfL concentration was 19 (interquartile range [IQR] 11–31) pg/ml in patients with good outcome and 2343 (587–5829) pg/ml in those with poor outcome, p < 0.001. NfL predicted poor outcome with an area under the receiver operating characteristic curve (AUROC) of 0.98 (95% confidence interval [CI] 0.97–1.00) at 24 h, 0.98 (0.97–1.00) at 48 h, and 0.98 (0.95–1.00) at 72 h. NfL concentrations were lower in the higher MAP (80–100 mmHg) group than in the lower MAP (65–75 mmHg) group at 48 h (median, 23 vs. 43 pg/ml, p = 0.04). PaCO2 and PaO2 targets did not associate with NfL levels. Conclusions NfL demonstrated excellent prognostic accuracy after OHCA. Higher MAP was associated with lower NfL concentrations.

22 October 2025 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
JNJerry P. Nolan
Jerry P. Nolan
CSClaudio Sandroni
Claudio Sandroni
ACAlain Cariou
Alain Cariou
TCTobias Cronberg
Tobias Cronberg
SDSonia D'Arrigo
Sonia D'Arrigo
JSJasmeet Soar
Jasmeet Soar

1 April 2019 in Resuscitation
Verified
Journal Article
Open access
JYJ. Yeung
J. Yeung
TMTasuku Matsuyama
Tasuku Matsuyama
JBJ. Bray
J. Bray
JRJ. Reynolds
J. Reynolds
MSMarkus Skrifvars
Markus Skrifvars
To perform a systematic review to answer 'In adults with attempted resuscitation after non-traumatic cardiac arrest does care at a specialised cardiac arrest centre (CAC) compared to care in a healthcare facility not designated as a specialised cardiac arrest centre improve patient outcomes?' The PRISMA guidelines were followed. We searched bibliographic databases (Embase, MEDLINE and the Cochrane Library (CENTRAL)) from inception to 1st August 2018. Randomised controlled trials (RCTs) and non-randomised studies were eligible for inclusion. Two reviewers independently scrutinized studies for relevance, extracted data and assessed quality of studies. Risk of bias of studies and quality of evidence were assessed using ROBINS-I tool and GRADEpro respectively. Primary outcomes were survival to 30 days with favourable neurological outcomes and survival to hospital discharge with favourable neurological outcomes. Secondary outcomes were survival to 30 days, survival to hospital discharge and return of spontaneous circulation (ROSC) post-hospital arrival for patients with ongoing resuscitation. This systematic review was registered in PROSPERO (CRD 42018093369) RESULTS: We included data from 17 observational studies on out-of-hospital cardiac arrest (OHCA) patients in meta-analyses. Overall, the certainty of evidence was very low. Pooling data from only adjusted analyses, care at CAC was not associated with increased likelihood of survival to 30 days with favourable neurological outcome (OR 2.92, 95% CI 0.68-12.48) and survival to 30 days (OR 2.14, 95% CI 0.73-6.29) compared to care at other hospitals. Whereas patients cared for at CACs had improved survival to hospital discharge with favourable neurological outcomes (OR 2.22, 95% CI 1.74-2.84) and survival to hospital discharge (OR 1.85, 95% CI 1.46-2.34). Very low certainty of evidence suggests that post-cardiac arrest care at CACs is associated with improved outcomes at hospital discharge. There remains a need for high quality data to fully elucidate the impact of CACs.

1 August 2016 in Resuscitation
Verified
Journal Article
Closed access
JLJohanna Laurikkala
Johanna Laurikkala
EWErika Wilkman
Erika Wilkman
VPVille Pettilä
Ville Pettilä
JKJouni Kurola
Jouni Kurola
MRMatti Reinikainen
Matti Reinikainen
MSMarkus Skrifvars
Markus Skrifvars